Article Versions Notes

Kang B, Zhang X, Wang W, She S, Chen W, Chen C, Wang Y, Pan X, Xu O, Wang Y. The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole against Colorectal Cancer. Cancers. 2022; 14(23):5747. https://doi.org/10.3390/cancers14235747

Kang, Bo, Xiaobing Zhang, Weibing Wang, Shiqi She, Wenjie Chen, Cheng Chen, Yisha Wang, Xiaoyun Pan, Ouyuan Xu, and Yingjie Wang. 2022. "The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole against Colorectal Cancer" Cancers 14, no. 23: 5747. https://doi.org/10.3390/cancers14235747

Kang, B., Zhang, X., Wang, W., She, S., Chen, W., Chen, C., Wang, Y., Pan, X., Xu, O., & Wang, Y. (2022). The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole against Colorectal Cancer. Cancers, 14(23), 5747. https://doi.org/10.3390/cancers14235747